Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference
Olanrewaju Ayodeji Durojaye, Nkwachukwu Oziamara Okoro, Arome Solomon Odiba, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Pharmacophore-based identification and in Silico characterization of microbial metabolites as potential modulators of Wnt signaling pathway in colorectal cancer therapy
Divya Sharma, Sivakumar Arumugam
Molecular Diversity (2025)
Closed Access | Times Cited: 1
Revolutionizing drug discovery: an AI-powered transformation of molecular docking
Adeola Abraham Fadahunsi, Henrietta Onyinye Uzoeto, Nkwachukwu Oziamara Okoro, et al.
Medicinal Chemistry Research (2024)
Closed Access | Times Cited: 5
Investigation of the MDM2-binding potential of de novo designed peptides using enhanced sampling simulations
Olanrewaju Ayodeji Durojaye, Abeeb Abiodun Yekeen, Mukhtar Oluwaseun Idris, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131840-131840
Closed Access | Times Cited: 4
Antibacterial activity analysis of kaempferol and its derivatives targeting virulence and quorum sensing associated proteins by in silico methods
Golak Majumdar, Shyamapada Mandal
The Microbe (2025), pp. 100259-100259
Open Access
CSC01 shows promise as a potential inhibitor of the oncogenic G13D mutant of KRAS: an in silico approach
Olanrewaju Ayodeji Durojaye, Umer Ejaz, Henrietta Onyinye Uzoeto, et al.
Amino Acids (2023) Vol. 55, Iss. 12, pp. 1745-1764
Closed Access | Times Cited: 6
Lansoprazole as a potent HDAC2 inhibitor for treatment of colorectal cancer: An in-silico analysis and experimental validation
Saedeh Khadempar, Marzieh Lotfi, Fatemeh Haghiralsadat, et al.
Computers in Biology and Medicine (2023) Vol. 166, pp. 107518-107518
Closed Access | Times Cited: 5
In Silico Evaluation of Bioactive Compounds of Citrullus lanatus as Potential Noncovalent KRAS Inhibitors in the Treatment of Human Cancer
Oluwatoba Emmanuel Oyeneyin, Nureni Ipinloju, Renato Araújo da Costa, et al.
Chemistry Africa (2024) Vol. 7, Iss. 5, pp. 2553-2567
Closed Access | Times Cited: 1
E-pharmacophore and Deep learning based high throughput virtual screening for identification of CDPK1 inhibitors of Cryptosporidium parvum
Misgana Mengistu Asmare, Soon‐Il Yun
Computational Biology and Chemistry (2024) Vol. 112, pp. 108172-108172
Closed Access
p70S6K as a Potential Anti-COVID-19 Target: Insights from Wet Bench and In Silico Studies
Sharon Shechter, Rajat Kumar Pal, Fabio Trovato, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1760-1760
Open Access
Identification of natural compound inhibitors for substrate-binding site of MTHFD2 enzyme: Insights from structure-based drug design and biomolecular simulations
Nisarg Rana, Priyanka Solanki, Rukmankesh Mehra, et al.
Chemical Physics Impact (2024), pp. 100809-100809
Open Access
Identification of anti-cancer organometallic compounds by inhibition of BCL-2/Bax interactions
Mohd Afzal, Abdullah Alarifi, Naaser A. Y. Abduh, et al.
Computers in Biology and Medicine (2023) Vol. 167, pp. 107657-107657
Closed Access | Times Cited: 1
Page 1

Scroll to top